NEWS & INSIGHTS

Latest News
Exscientia raises $60 million in Series C financing round led by Novo Holdings
Read Now

All

Exscientia raises $60 million in Series C financing round led by Novo Holdings

READ MORE

SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence

READ MORE

Exscientia announces joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps Research

READ MORE

TheGuardian: Oxford firm to screen 15,000 drugs in search for coronavirus cure

READ MORE

Artificial Intelligence Could Fight a Future Coronavirus

READ MORE

Financial Times : Read the article detailing Exscientia's work on the first AI-designed drug to enter clinical trials.

READ MORE

Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial

READ MORE

Artificial intelligence-created medicine to be used on humans for first time

READ MORE

Exscientia appoints Dr. David Hallett as Chief Operating Officer as company positions for further growth

READ MORE
  • <<
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • >>